| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | APBB1IP | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | ARFRP1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | VMA21 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | KCNE5 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | RP11-762I7.5 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | MT1M | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
